HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preoperative chemotherapy for mesoblastic nephroma.

Abstract
A neonate with extensive stage III mesoblastic nephroma was confirmed at operation to have a tumor that was too infiltrative and too advanced for primary excision. The abdomen was closed after multiple biopsies. Vincristine (1.1 mg/m2) was given intravenously once a week for a total of eight doses. Repeat CT scan confirmed shrinkage of the tumor and a nephrectomy could be performed safely and the tumor removed at the second laparotomy. CT scan repeated 1 year later showed no recurrence. This case illustrates the effective use of a single drug pre-excision chemotherapy which allowed a nephrectomy for extensive stage III mesoblastic nephroma to be carried out safely.
AuthorsK L Chan, K W Chan, C W Lee, H Saing
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 24 Issue 4 Pg. 271-3 (Apr 1995) ISSN: 0098-1532 [Print] United States
PMID7700175 (Publication Type: Case Reports, Journal Article)
Topics
  • Combined Modality Therapy
  • Female
  • Humans
  • Infant, Newborn
  • Kidney Neoplasms (congenital, drug therapy, surgery)
  • Nephrectomy
  • Nephroma, Mesoblastic (congenital, drug therapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: